This role involves leading late-stage cell therapy programs, specifically within prostate cancer, to redefine patient outcomes. The position focuses on transforming scientific advancements into clinical evidence that can inform global regulators, payers, and clinicians. The individual will be responsible for shaping study design, overseeing conduct and monitoring, and driving data interpretation to establish the benefit-risk profile, intended label, and global value proposition. The role requires translating novel biology into pivotal trials that meet regulatory standards and achieve real-world impact. Collaboration with diverse expert teams and external partners is key to co-leading product and study strategy, setting a clear vision, and enabling timely decisions. The use of innovative tools, including biomarkers and advanced trial designs, is encouraged to maintain program competitiveness and accelerate the delivery of transformative therapies to patients.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Associate degree